Clouding the G-7 gathering, which represents the world's major industrial economies, are the tit-for-tat tariffs between Washington and Beijing.Politicsread more
The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:
Monster Beverage: "Monster Beverage had a really good quarter. I think they're doing incredibly well, but they have a big business in Europe so people are going to freak out. I think under $150 it's getting interesting. Not yet though."
Alnylam Pharmaceuticals: "This is a big speculative stock. Obviously this market abhors speculation, but it's very low. No ... you're going to lose money I believe in that stock. You've just got to wait a little bit."
Oasis Petroleum: "No, Oasis peaked because it's in Williston. Not going to go there."
Cigna: "That merger I think is dead on arrival. I do believe, however, that that is a stock that you want to own. My favorite in that group is United Healthcare."
Emerge Energy Services: "Oil is done going down big. I think that you should sell half and let the rest run."